Our providers treat common illnesses, manage chronic conditions, and offer preventive care to help patients stay healthy year-round
October 2, 2024: The FDA updated the status for tirzepatide injections on the shortage list from Currently in Shortage to Resolved. This change meant that Tirzepatide injections, marketed under the brand names Zepbound and Mounjaro by Eli Lilly, could no longer be compounded by 503A Compounding Pharmacies or 503B Outsourcing Facilities
Oral capsules deliver less than a quarter
For a 5mg vial, add 2mL of bacteriostatic water
Comprehensive Evaluation We will conduct a comprehensive evaluation, including blood tests and other diagnostic measures, to assess your overall health and determine if Semaglutide is a suitable option for you
a digital twin) and uncover subtle, complex patterns (like, for example, how a specific sleep pattern interacts with a genetic marker to influence the GLP-1's effect)